Importance of Pharmacotherapeutic Follow-Up in Odontopediatrics

Abstract

The most common cause of admission to the Pediatric Dentistry service is dental pain, active deafness and an oppressive sensation that is sometimes throbbing and burning. Pharmacotherapy in Pediatric Dentistry must be effective, safe, and rational in neonates, infants, and children. The pharmacotherapeutic follow-up of pediatric patients from Integral Clinic of the Odontopediatric Specialty (CLIO) and Kindergarten Clinic (CLIJANI), Autonomous University of Zacatecas (UAZ) was carried out. Through an observational, exploratory, and cross-sectional study, 23 patients from the Pediatric Dentistry Specialty Clinic (CLIO/UAO/UAZ) and 35 clinical records of patients from CLIJANI, from August 2019-2020, were analyzed. Prior authorization for the patient, an interview, and pharmacotherapeutic follow-up were performed, recording data on the indicated drug, the dose, and the schedule of use. On carrying out the interview on pharmacotherapy with the parents or guardians who accompany the patient, 91.3% of the pediatric patients were not administered pharmacological treatment. It was observed that there is no adequate adherence to the pharmacological treatment in pediatric patients.